Neuregulin and erbB receptor expression in normal and diseased human white matter

Journal of Neuroimmunology - Tập 100 - Trang 233-242 - 1999
Barbara Cannella1, David Pitt2, Mark Marchionni3, Cedric S Raine1,2,4
1Department of Pathology (Neuropathology), F140, Albert Einstein College of Medicine 1300 Morris Park Avenue, Bronx, NY 10461-1602, USA
2Department of Neurology, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461-1602, USA
3Cambridge NeuroSciences, 1 Kendall Square, Cambridge, MA 02139, USA
4Department of Neuroscience, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461-1602, USA

Tài liệu tham khảo

Brosnan, 1996, Mechanisms of immune injury in multiple sclerosis, Brain Pathol., 6, 243, 10.1111/j.1750-3639.1996.tb00853.x Burden, 1997, Neuregulins and their receptors: a versatile signaling module in organogenesis and oncogenesis, Neuron, 18, 847, 10.1016/S0896-6273(00)80324-4 Cannella, 1995, The adhesion molecule and cytokine profile of multiple sclerosis lesions, Ann. Neurol., 37, 424, 10.1002/ana.410370404 Cannella, 1998, The neuregulin, GGF2, diminishes autoimmune demyelination and enhances remyelination in a chronic relapsing model for multiple sclerosis, Proc. Natl. Acad. Sci., 95, 10100, 10.1073/pnas.95.17.10100 Canoll, 1996, GGF/neuregulin is a neuronal signal that promotes the proliferation and survival and inhibits the differentiation of oligodendrocyte progenitors, Neuron, 17, 229, 10.1016/S0896-6273(00)80155-5 Carraway, 1995, Neuregulins and their receptors, Curr. Opin. Neurobiol., 5, 606, 10.1016/0959-4388(95)80065-4 Carroll, 1997, Expression of neuregulins and their putative receptors, erbB2 and erbB3 is induced during Wallerian degeneration, J. Neurosci., 17, 1642, 10.1523/JNEUROSCI.17-05-01642.1997 Chen, 1994, Expression of multiple neuregulin transcripts in postnatal rat brains, J. Comp. Neurol., 349, 389, 10.1002/cne.903490306 Cohen, 1992, Expression of the neu proto-oncogene by Schwann cells during peripheral nerve development and Wallerian degeneration, J. Neurosci. Res., 31, 622, 10.1002/jnr.490310406 Corfas, 1995, Differential expression of ARIA isoforms in the rat brain, Neuron, 14, 103, 10.1016/0896-6273(95)90244-9 Grinspan, 1996, Axonal interactions regulate Schwann cell apoptosis in developing peripheral nerve: neuregulin receptors and the role of neuregulins, J. Neurosci., 16, 6107, 10.1523/JNEUROSCI.16-19-06107.1996 Hart, 1989, PDGF receptors on cells of the oligodendrocyte-type 2 astrocyte (0-2A) cell lineage, Development, 105, 595, 10.1242/dev.105.3.595 Jo, 1995, Neuregulins are concentrated at nerve-muscle synapses and activate Ach-receptor gene expression, Nature, 373, 158, 10.1038/373158a0 Karunayaran, 1996, erbB-2 is a common auxiliary subunit of NDF and EGF receptors: implications for breast cancer, EMBO J., 15, 254, 10.1002/j.1460-2075.1996.tb00356.x Kokai, 1987, Stage- and tissue-specific expression of the new oncogene in rat development, Proc. Natl. Acad. Sci. U.S.A., 84, 8498, 10.1073/pnas.84.23.8498 Kraus, 1989, Isolation and characterization of erbB3, a third member of the ERBB/epidermal growth factor receptor family: evidence for overexpression in a subset of human mammary tumors, Proc. Natl. Acad. Sci. U.S.A., 86, 9193, 10.1073/pnas.86.23.9193 Lemke, 1996, Neuregulins in development, Mol. Cell. Neurosci., 7, 247, 10.1006/mcne.1996.0019 Levine, 1987, Plasticity of developing cerebellar cells in vitro studied with antibodies against the NG2 antigen, J. Neurosci., 7, 2721, 10.1523/JNEUROSCI.07-09-02721.1987 Lumsden, C.E., 1970. The neuropathology of multiple sclerosis. In: Vinken, P.J., Bruyn, G.W. (Eds.), Handbook of Clinical Neurology, Vol. 9. North-Holland, Amsterdam, pp. 217–309. Marchionni, 1996, Neuregulins as potential drugs for neurological disorders, Cold Spring Harbor Symp. Quant. Biol., 61, 459, 10.1101/SQB.1996.061.01.048 Minghetti, 1996, Glial growth factors I–III are specific mitogens for glial cells, J. Neurosci. Res., 43, 684, 10.1002/(SICI)1097-4547(19960315)43:6<684::AID-JNR5>3.0.CO;2-A Neumann, 1998, Neuronal control of the immune response in the central nervous system: linking brain immunity to neurodegeneration, J. Neuropathol. Exp. Neurol., 57, 1, 10.1097/00005072-199801000-00001 Perry, 1992, Role of macrophages in peripheral nerve degeneration and repair, BioEssays, 14, 401, 10.1002/bies.950140610 Pinkas-Kramarski, 1996, Diversification of Neu differentiation factor and epidermal growth factor signaling by combinatorial receptor interactions, EMBO J., 15, 2452, 10.1002/j.1460-2075.1996.tb00603.x Pinkas-Kramarski, 1997, Differential expression of NDF/neuregulin receptors erbB-3 and erbB-4 and involvement in inhibition of neuronal differentiation, Oncogene, 15, 2803, 10.1038/sj.onc.1201466 Plowman, 1993, Ligand-specific activation of HER4/p180 erbB4, a fourth member of the epidermal growth factor receptor family, Proc. Natl. Acad. Sci. U.S.A., 90, 1746, 10.1073/pnas.90.5.1746 Prineas, J.W., McDonald, W.I., 1997. Demyelinating diseases. In: Graham, D.I., Lantos, P.L. (Eds.), Greenfield's Neuropathology, Vol. 1. Arnold, London, pp. 813–896. Prineas, 1989, Multiple sclerosis: oligodendrocyte proliferation and differentiation in fresh lesions, Lab. Invest., 61, 489 Prineas, 1993, Multiple sclerosis: remyelination of nascent lesions, Ann. Neurol., 33, 137, 10.1002/ana.410330203 Raabe, 1997, Neonatal oligodendrocytes contain and secrete neuregulins in vitro, J. Neurochem., 69, 1859, 10.1046/j.1471-4159.1997.69051859.x Raine, C.S., 1997. The neuropathology of multiple sclerosis. In: Raine, C.S., McFarland, H.F., Tourtellotte, W.W. (Eds.), Multiple Sclerosis Clinical and Pathogenetic Basis. Chapman & Hall, London, pp. 151–172. Raine, 1993, Multiple sclerosis: remyelination in acute lesions, J. Neuropathol. Exp. Neurol., 52, 199, 10.1097/00005072-199305000-00003 Raine, 1981, Multiple sclerosis: oligodendrocyte survival and proliferation in an active, established lesion, Lab. Invest., 45, 534 Raine, 1998, Multiple sclerosis: expression of molecules of the tumor necrosis factor ligand and receptor families in relationship to the demyelinated plaque, Rev. Neurol., 154, 577 Schechter, 1984, The neu oncogene: an erbB-related gene encoding a 185,000-M tumour antigen, Nature, 312, 513, 10.1038/312513a0 Scolding, 1998, Oligodendrocyte progenitors are present in the normal adult human CNS and in the lesions of multiple sclerosis, Brain, 121, 2221, 10.1093/brain/121.12.2221 Sliwkowski, 1994, Coexpression of erbB2 and erbB3 proteins reconstitutes a high affinity receptor for heregulin, J. Biol. Chem., 269, 14661, 10.1016/S0021-9258(17)36676-0 Trachtenberg, 1996, Schwann cell apoptosis at developing neuromuscular junctions is regulated by glial growth factor, Nature, 379, 174, 10.1038/379174a0 Vartanian, 1999, Failure of spinal cord oligodendrocyte development in mice lacking neuregulin, Proc. Natl. Acad. Sci. U.S.A., 96, 731, 10.1073/pnas.96.2.731 Wallasch, 1995, Heregulin-dependent regulation of HER2/neu oncogenic signaling by heterodimerization with HER3, EMBO J., 14, 4267, 10.1002/j.1460-2075.1995.tb00101.x Wolswijk, 1998, Chronic stage multiple sclerosis lesions contain a relatively quiescent population of oligodendrocyte precursor cells, J. Neurosci., 18, 601, 10.1523/JNEUROSCI.18-02-00601.1998